Literature DB >> 22258563

Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins.

H H J Gerets1, K Tilmant, B Gerin, H Chanteux, B O Depelchin, S Dhalluin, F A Atienzar.   

Abstract

In the pharmaceutical industry, improving the early detection of drug-induced hepatotoxicity is essential as it is one of the most important reasons for attrition of candidate drugs during the later stages of drug development. The first objective of this study was to better characterize different cellular models (i.e., HepG2, HepaRG cells, and fresh primary human hepatocytes) at the gene expression level and analyze their metabolic cytochrome P450 capabilities. The cellular models were exposed to three different CYP450 inducers; beta-naphthoflavone (BNF), phenobarbital (PB), and rifampicin (RIF). HepG2 cells responded very weakly to the different inducers at the gene expression level, and this translated generally into low CYP450 activities in the induced cells compared with the control cells. On the contrary, HepaRG cells and the three human donors were inducible after exposure to BNF, PB, and RIF according to gene expression responses and CYP450 activities. Consequently, HepaRG cells could be used in screening as a substitute and/or in complement to primary hepatocytes for CYP induction studies. The second objective was to investigate the predictivity of the different cellular models to detect hepatotoxins (16 hepatotoxic and 5 nonhepatotoxic compounds). Specificity was 100% with the different cellular models tested. Cryopreserved human hepatocytes gave the highest sensitivity, ranging from 31% to 44% (depending on the donor), followed by lower sensitivity (13%) for HepaRG and HepG2 cells (6.3%). Overall, none of the models under study gave desirable sensitivities (80-100%). Consequently, a high metabolic capacity and CYP inducibility in cell lines does not necessarily correlate with a high sensitivity for the detection of hepatotoxic drugs. Further investigations are necessary to compare different cellular models and determine those that are best suited for the detection of hepatotoxic compounds.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22258563      PMCID: PMC3303072          DOI: 10.1007/s10565-011-9208-4

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  38 in total

1.  Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes.

Authors:  M Teresa Donato; Nuria Jiménez; José V Castell; M José Gómez-Lechón
Journal:  Drug Metab Dispos       Date:  2004-07       Impact factor: 3.922

2.  Toxicity testing in the 21st century: a view from the pharmaceutical industry.

Authors:  James S MacDonald; Richard T Robertson
Journal:  Toxicol Sci       Date:  2009-05-12       Impact factor: 4.849

3.  Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.

Authors:  S R Faucette; R L Hawke; E L Lecluyse; S S Shord; B Yan; R M Laethem; C M Lindley
Journal:  Drug Metab Dispos       Date:  2000-10       Impact factor: 3.922

4.  Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity.

Authors:  R E Pearce; C J McIntyre; A Madan; U Sanzgiri; A J Draper; P L Bullock; D C Cook; L A Burton; J Latham; C Nevins; A Parkinson
Journal:  Arch Biochem Biophys       Date:  1996-07-15       Impact factor: 4.013

5.  High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.

Authors:  P J O'Brien; W Irwin; D Diaz; E Howard-Cofield; C M Krejsa; M R Slaughter; B Gao; N Kaludercic; A Angeline; P Bernardi; P Brain; C Hougham
Journal:  Arch Toxicol       Date:  2006-04-06       Impact factor: 5.153

6.  Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes.

Authors:  Ajay Madan; Richard A Graham; Kathleen M Carroll; Daniel R Mudra; L Alayne Burton; Linda A Krueger; April D Downey; Maciej Czerwinski; Jameson Forster; Maria D Ribadeneira; Liang-Shang Gan; Edward L LeCluyse; Karl Zech; Philmore Robertson; Patrick Koch; Lida Antonian; Greg Wagner; Li Yu; Andrew Parkinson
Journal:  Drug Metab Dispos       Date:  2003-04       Impact factor: 3.922

7.  Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.

Authors:  Walter M A Westerink; Willem G E J Schoonen
Journal:  Toxicol In Vitro       Date:  2007-07-18       Impact factor: 3.500

8.  Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers.

Authors:  Stephanie R Faucette; Hongbing Wang; Geraldine A Hamilton; Summer L Jolley; Darryl Gilbert; Celeste Lindley; Bingfang Yan; Masahiko Negishi; Edward L LeCluyse
Journal:  Drug Metab Dispos       Date:  2004-03       Impact factor: 3.922

9.  Evaluation of genes identified by microarray analysis in favorable neuroblastoma.

Authors:  Naomi Kamei; Keiko Hiyama; Hiroaki Yamaoka; Arata Kamimatsuse; Yoshiyuki Onitake; Taijiro Sueda; Eiso Hiyama
Journal:  Pediatr Surg Int       Date:  2009-11       Impact factor: 1.827

10.  Cellular imaging predictions of clinical drug-induced liver injury.

Authors:  Jinghai J Xu; Peter V Henstock; Margaret C Dunn; Arthur R Smith; Jeffrey R Chabot; David de Graaf
Journal:  Toxicol Sci       Date:  2008-06-03       Impact factor: 4.849

View more
  160 in total

1.  Evaluation of CYP3A4 inhibition and hepatotoxicity using DMSO-treated human hepatoma HuH-7 cells.

Authors:  Yitong Liu; Thomas J Flynn; Menghang Xia; Paddy L Wiesenfeld; Martine S Ferguson
Journal:  Cell Biol Toxicol       Date:  2015-09-16       Impact factor: 6.691

2.  Genome-wide analysis of human constitutive androstane receptor (CAR) transcriptome in wild-type and CAR-knockout HepaRG cells.

Authors:  Daochuan Li; Bryan Mackowiak; Timothy G Brayman; Michael Mitchell; Lei Zhang; Shiew-Mei Huang; Hongbing Wang
Journal:  Biochem Pharmacol       Date:  2015-08-12       Impact factor: 5.858

3.  Regulation of Cytosolic Sulfotransferases in Models of Human Hepatocyte Development.

Authors:  Sarah Dubaisi; Kathleen G Barrett; Hailin Fang; Jorge Guzman-Lepe; Alejandro Soto-Gutierrez; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Drug Metab Dispos       Date:  2018-06-01       Impact factor: 3.922

Review 4.  Drug-induced steatohepatitis.

Authors:  Ajit Dash; Robert A Figler; Arun J Sanyal; Brian R Wamhoff
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-10-27       Impact factor: 4.481

5.  Microfluidic organs-on-chips.

Authors:  Sangeeta N Bhatia; Donald E Ingber
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

6.  Melatonin attenuates cisplatin-induced HepG2 cell death via the regulation of mTOR and ERCC1 expressions.

Authors:  Kangsadarn Bennukul; Sucha Numkliang; Vijittra Leardkamolkarn
Journal:  World J Hepatol       Date:  2014-04-27

7.  Transcriptome profiling of HepG2 cells exposed to the flame retardant 9,10-dihydro-9-oxa-10-phosphaphenanthrene 10-oxide (DOPO).

Authors:  Boris V Krivoshiev; Gerrit T S Beemster; Katrien Sprangers; Bart Cuypers; Kris Laukens; Ronny Blust; Steven J Husson
Journal:  Toxicol Res (Camb)       Date:  2018-03-12       Impact factor: 3.524

8.  One Standardized Differentiation Procedure Robustly Generates Homogenous Hepatocyte Cultures Displaying Metabolic Diversity from a Large Panel of Human Pluripotent Stem Cells.

Authors:  Annika Asplund; Arvind Pradip; Mariska van Giezen; Anders Aspegren; Helena Choukair; Marie Rehnström; Susanna Jacobsson; Nidal Ghosheh; Dorra El Hajjam; Sandra Holmgren; Susanna Larsson; Jörg Benecke; Mariela Butron; Annelie Wigander; Karin Noaksson; Peter Sartipy; Petter Björquist; Josefina Edsbagge; Barbara Küppers-Munther
Journal:  Stem Cell Rev Rep       Date:  2016-02       Impact factor: 5.739

9.  Optimization of Canalicular ABC Transporter Function in HuH-7 Cells by Modification of Culture Conditions.

Authors:  Hee Eun Kang; Melina M Malinen; Chitra Saran; Paavo Honkakoski; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2019-08-01       Impact factor: 3.922

10.  Repression of hepatocyte nuclear factor 4 alpha by AP-1 underlies dyslipidemia associated with retinoic acid.

Authors:  Kyoung-Jae Won; Joo-Seop Park; Hyunyoung Jeong
Journal:  J Lipid Res       Date:  2019-02-01       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.